E2F1 and prostate carcinoma: Taken together, these findings suggest that deregulation of the MYC/E2F1/RB1 cell-cycle regulator axis by various means is a ubiquitous event in AR indifferent prostate cancer that is necessary to overcome the G1 arrest caused by low AR activity.